The cultural narrative surrounding BRCA1 and BRCA2 genetic mutations has long been framed as a "women’s issue." Historically associated with breast and ovarian cancers, the conversation has frequently sidelined the critical role men play in this genetic landscape. However, the harrowing and ultimately transformative experience of cancer survivor and advocate Doug Bank serves as a powerful testament to a different reality: BRCA mutations are a family issue, and for men, knowledge is not just power—it is a lifeline.
Doug Bank’s story, spanning three decades and multiple cancer diagnoses within his family, highlights a critical gap in public health awareness. From his own struggle with testicular and prostate cancers to the loss of his brother to pancreatic cancer and his daughter’s early-onset breast cancer, Bank’s journey underscores the necessity of male involvement in genetic screening. As a member of the Sharsheret Men’s Leadership Council, Bank is now working to ensure that no man—and no family—is left in the dark regarding their genetic heritage.
Main Facts: The Intersection of Gender and Genetics
The BRCA1 and BRCA2 genes (BReast CAncer genes) are tumor suppressors. When these genes are mutated, they fail to repair DNA damage effectively, significantly increasing the risk of various cancers. While the focus remains heavily on female-centric risks, the medical reality is that these mutations are autosomal dominant; they are not linked to the X or Y chromosomes, meaning men and women have an equal 50% chance of inheriting the mutation from an affected parent and an equal chance of passing it on to their children.
For men, a BRCA2 mutation, in particular, is associated with:
- Prostate Cancer: A significantly higher risk of developing aggressive, high-grade prostate cancer at a younger age.
- Male Breast Cancer: While rare in the general population, the risk increases substantially for BRCA carriers.
- Pancreatic Cancer: Both men and women with BRCA mutations face an elevated risk of this difficult-to-treat malignancy.
- Melanoma: Some studies suggest an increased risk of skin and ocular melanoma.
Doug Bank’s personal history embodies these statistics. His diagnosis of BRCA2 in 2009 served as the "missing link" that explained a generational pattern of illness. His experience highlights a systemic issue: men are often the "hidden carriers" who may not develop symptoms themselves but act as the conduit for high-risk genetic traits that affect their daughters, sons, and siblings.
Chronology: A Thirty-Year Medical Odyssey
1990s: The Initial Catalyst
At the age of 26, Doug Bank was diagnosed with Stage I testicular cancer. At the time, testicular cancer was not commonly linked to BRCA mutations (and generally remains outside the primary BRCA spectrum). However, this initial brush with mortality served as his entry point into patient advocacy. Bank faced an overly aggressive treatment recommendation—a common occurrence in an era before "active surveillance" became a standard for early-stage testicular cancer. His successful navigation of his own treatment led him to found a nonprofit and an email support group to help other men navigate the fear and confusion of a cancer diagnosis.
The LIVESTRONG Years and Sharsheret
During his work with the LIVESTRONG Young Adult Alliance, Bank met Rochelle Shoretz, the founder of Sharsheret, an organization dedicated to supporting Jewish women and families facing breast and ovarian cancer. While Bank did not yet know his genetic status, this meeting planted a seed that would later grow into a vital support system for his family.
2009: The Pedigree Revelation
The turning point came when a routine inquiry by his wife’s physician prompted Bank to look closer at his own paternal lineage. Despite his extensive background in cancer advocacy, Bank initially resisted genetic testing. It was only after constructing a "pedigree"—a detailed family medical tree—that the pattern became undeniable. His father had prostate cancer; his aunt had breast cancer; and every one of his father’s female cousins had been diagnosed with breast or ovarian cancer. In 2009, Bank tested positive for the BRCA2 mutation.
The Family Impact: Pancreatic and Breast Cancer
The revelation of the BRCA2 mutation provided a somber explanation for his brother’s subsequent diagnosis of pancreatic cancer. While the knowledge came too late to prevent the disease, it allowed for more targeted treatments that extended his brother’s life by nearly five years.
The most poignant chapter of the chronology involves Bank’s daughter. Despite medical pushback against testing young adults due to potential anxiety, Bank insisted his children know their status. Two of his children tested positive. Because his daughter was aware of her high-risk status, she was under the care of a specialist. When she discovered a lump at age 24, her concerns were taken seriously. Unlike many young women whose symptoms are dismissed due to their age, she received immediate, life-saving treatment.
56: The Circle Closes
In a final validation of the genetic risk, Bank himself was diagnosed with prostate cancer at age 56. Because of his known BRCA2 status, the diagnosis was caught early and managed with the specific clinical understanding that BRCA-linked prostate cancers tend to be more aggressive.
Supporting Data: The Statistics of Risk
The implications of Doug Bank’s story are supported by a growing body of clinical data regarding BRCA mutations in men.
- Inheritance Patterns: A man with a BRCA mutation has a 50% chance of passing it to each of his children. A daughter who inherits a BRCA1 mutation from her father has up to an 80% lifetime risk of breast cancer.
- Prostate Cancer Risk: Research indicates that men with a BRCA2 mutation have a 20% to 25% lifetime risk of developing prostate cancer, compared to roughly 12% in the general population. Furthermore, these cases are often diagnosed at a more advanced stage if not monitored closely.
- The Ashkenazi Connection: Sharsheret’s focus on the Jewish community is rooted in data showing that individuals of Ashkenazi Jewish descent have a 1 in 40 chance of carrying a BRCA mutation, compared to roughly 1 in 400 in the general population. This makes genetic literacy particularly vital for Jewish men.
- Male Breast Cancer: While the lifetime risk for men in the general population is 0.1%, for BRCA2 carriers, that risk jumps to approximately 7%.
Official Responses and Clinical Perspectives
The medical community has gradually shifted its stance on testing men, though barriers remain. Organizations like Sharsheret and the American Society of Clinical Oncology (ASCO) emphasize that genetic counseling is a prerequisite for testing.
The Role of Genetic Counselors: Experts argue that a genetic counselor is essential to help men understand that a positive result is not a "death sentence" but a roadmap for surveillance. For men, this often includes earlier and more frequent PSA (Prostate-Specific Antigen) tests and, in some cases, clinical breast exams.
Sharsheret’s Expansion: Historically focused on women, Sharsheret has expanded its reach through initiatives like the Men’s Leadership Council. Their official stance is that "cancer is a family affair." By involving men, the organization aims to break the stigma that genetic testing is a sign of weakness or a threat to masculinity.
The Controversy of Testing Young Adults: Bank’s experience with his daughter highlights a tension in the medical community. While some clinicians worry about the psychological burden of testing individuals in their early 20s, advocacy groups argue that "knowledge is power." The official response from high-risk clinics increasingly favors informed choice, acknowledging that for those with a known family mutation, the anxiety of not knowing can be more debilitating than the truth.
Implications: Changing the Conversation
The story of Doug Bank carries profound implications for the future of genetic medicine and family health.
Breaking the Gender Stigma
The primary implication is the need to degender the conversation around BRCA. When men view BRCA as a "women’s gene," they inadvertently put their own health and their children’s health at risk. Bank’s advocacy suggests that men must take an active role in "pedigree" tracking, ensuring that the family’s medical history is documented and shared across branches of the family tree.
The Power of Early Intervention
Bank’s daughter’s survival is a direct result of genetic literacy. The implication for public health is clear: early identification of BRCA status allows for a "high-risk surveillance" protocol that can catch cancers at Stage I or II, where they are most treatable, rather than Stage IV, where options are limited.
Psychological Resilience and Support
Finally, Bank’s involvement with Sharsheret underscores the importance of community. Genetic information can be isolating. For men, who may feel a sense of guilt for passing a mutation to their children, support networks are vital. The shift toward inclusive support structures ensures that the emotional burden of a genetic diagnosis is shared, rather than carried in silence.
Doug Bank’s journey from a young man with testicular cancer to a veteran advocate for genetic awareness serves as a roadmap for others. His message is clear: the risk does not disappear because we ignore it. By stepping into the conversation, men can help identify patterns of illness that have haunted their families for generations, ultimately turning a legacy of cancer into a legacy of proactive health and survival.
About the Author
